<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04330898</url>
  </required_header>
  <id_info>
    <org_study_id>RMN01</org_study_id>
    <nct_id>NCT04330898</nct_id>
  </id_info>
  <brief_title>Patients With Implantable Cardiac Devices Requiring a Nuclear Magnetic Resonance</brief_title>
  <acronym>RESONANCE</acronym>
  <official_title>Spanish Registry of Patients With Implantable Cardiac Devices That Require a Diagnostic Imaging Test With Nuclear Magnetic Resonance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Trialance SCCL</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Trialance SCCL</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The general objective of this registry is to study the number of patients carrying an
      implantable cardiac device that have an indication for an imaging diagnosis based on nuclear
      magnetic resonance. Is wanted to know the cause of the indication of the diagnostic test
      based on MRI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      MRI is currently infra indicated in patients with cardiac stimulation devices and for this
      reason, the request for this imaging technique in these patients is complicated and, often,
      the MRI-based test is replaced by a CT scan that may not be so beneficial for the diagnosis.

      Current data indicate that, with cardiological control and maintaining basic safety
      precautions, MRI could be performed in patients with peacemakers and Implantable Cardioverter
      Defibrillators (ICD) that require it for clinical reasons, although it should be noted that
      currently, due to lack of data published, the absolute safety of an MRI in these patients and
      the protocol used in each case cannot be guaranteed.

      This registry proposal is to have data of all patients implanted with Biotronik cardiac
      stimulation devices and evaluate how many of them have an indication for an MRI-based
      diagnostic test, how many of them are already undergoing this diagnostic test, how many are
      given an tomography as an alternative to avoid subjecting patients to an MRI
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 2, 2017</start_date>
  <completion_date type="Anticipated">July 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Percentage of patients with implantable cardiac devices that require a diagnostic test based on MRI</measure>
    <time_frame>1 year</time_frame>
    <description>statistical analysis of the variable</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Primary indication for MRI</measure>
    <time_frame>1 year</time_frame>
    <description>statistical analysis of the variable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reasons for not used MRI</measure>
    <time_frame>1 year</time_frame>
    <description>statistical analysis of the variable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients with a non-MRI-based test diagnosis, although they had an indication for an MRI-based diagnostic test because of their disease</measure>
    <time_frame>1 year</time_frame>
    <description>statistical analysis of the variable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost effectiveness of the he MRI Autodetect function</measure>
    <time_frame>1 year</time_frame>
    <description>statistical analysis of the variable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of the differences in the workflow</measure>
    <time_frame>1 year</time_frame>
    <description>statistical analysis of the variable</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1248</enrollment>
  <condition>Implantable Cardiac Device. Patients With a NMR Indication</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Biotronik peacemakers, implantable cardioverter-defibrillators and cardiac resynchronizers</intervention_name>
    <description>Any of these Biotronik cardiac stimulation devices with the Home Monitoring function activated for the remote control of patients</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Population with an accepted indication of an implantable cardiac device, including
        pacemakers, defibrillators and cardiac resynchronizers
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients carrying a cardiac stimulation device

          -  Patients able to understand the nature of the procedure

          -  Patients who give informed consent

        Exclusion Criteria:

          -  Epicardial cables

          -  Abandoned cables

          -  Non-BIOTRONIK cables

          -  Age &lt;18 years

          -  Pregnant and breastfeeding

          -  Subjects with irreversible brain damage caused by a pre-existing brain disease

          -  Heart transplant 6 months prior to recruitment or expected within the next 3 months

          -  Cardiac surgery 3 months prior to recruitment or planned for the next 3 months

          -  Life expectancy less than 12 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francisco Javier Alzueta, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Virgen de la Victoria</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francisco Ruiz Mateas, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Costa del Sol</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xavier Molina Figueras, PharmD, PhD</last_name>
    <phone>+ 34 689900009</phone>
    <email>xmolina@trialance.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marta Barbacid Hernández, PharmD, MSc</last_name>
    <phone>+34 630767668</phone>
    <email>mbarbacid@trialance.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital San Pedro de Alcantara</name>
      <address>
        <city>Cáceres</city>
        <state>Madrid</state>
        <zip>28015</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Barbacid Hernández, PharmD, MSc</last_name>
      <phone>+34630767668</phone>
      <email>mbarbacid@trialance.com</email>
    </contact>
    <contact_backup>
      <last_name>Concetta Chirico, PharmTechD</last_name>
      <phone>+34645494281</phone>
      <email>cchirico@trialance.com</email>
    </contact_backup>
    <investigator>
      <last_name>Maria Jose Garcia Ramos, Cardiology</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Poniente</name>
      <address>
        <city>El Ejido</city>
        <state>Madrid</state>
        <zip>28015</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta B Barbacid Hernández, PharmD, MSc</last_name>
      <phone>+34630767668</phone>
      <email>mbarbacid@trialance.com</email>
    </contact>
    <contact_backup>
      <last_name>Concetta Chirico, PharmTechD</last_name>
      <phone>+34645494281</phone>
      <email>cchirico@trialance.com</email>
    </contact_backup>
    <investigator>
      <last_name>Javier Fierro Rosón, Intensivist</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sofía García Ordoñez, Intensivist</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emilio Robles-Musso Castillo, Intensivist</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miguel Angel Fernández Ibáñez, Intensivist</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francisco Javier Vasserot Vargas, Intensivist</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Arquitecto Marcide</name>
      <address>
        <city>Ferrol</city>
        <state>Madrid</state>
        <zip>28015</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Barbacid Hernández, PharmD, MSc</last_name>
      <phone>+34630767668</phone>
      <email>mbarbacid@trialance.com</email>
    </contact>
    <contact_backup>
      <last_name>Concetta Chirico, PharmTechD</last_name>
      <phone>+34645494281</phone>
      <email>cchirico@trialance.com</email>
    </contact_backup>
    <investigator>
      <last_name>Fernando Garcia Lopez, Cardiology</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emiliano Fernandez/Obama Windscheid, Cardiology</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Galdakano</name>
      <address>
        <city>Galdakao</city>
        <state>Madrid</state>
        <zip>28015</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Barbacid Hernández, PharmD, MSc</last_name>
      <phone>+34630767668</phone>
      <email>mbarbacid@trialance.com</email>
    </contact>
    <contact_backup>
      <last_name>Concetta B Chirico, PharmD, MSc</last_name>
      <phone>+34645494281</phone>
      <email>cchirico@trilance.com</email>
    </contact_backup>
    <investigator>
      <last_name>Javier Zumalde Otegui, Cardiology</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alaitz Romero, Cardiology</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>German Zugazabeitia, Cardiology</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Orense</name>
      <address>
        <city>Orense</city>
        <state>Madrid</state>
        <zip>28015</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Barbacid Hernández, PharmD, MSc</last_name>
      <phone>+34630767668</phone>
      <email>mbarbacid@trialance.com</email>
    </contact>
    <contact_backup>
      <last_name>Concetta Chirico, PharmTechD</last_name>
      <phone>+34645494281</phone>
      <email>cchirico@trialance.com</email>
    </contact_backup>
    <investigator>
      <last_name>Marcos Antonio Perez Veloso, Cardiology</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Beariz Gonzalez Chana, Cardiology</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General de Asturias</name>
      <address>
        <city>Oviedo</city>
        <state>Madrid</state>
        <zip>28015</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Barbacid Hernández, PharmD, MSc</last_name>
      <phone>+34630767668</phone>
      <email>mbarbacid@trialance.com</email>
    </contact>
    <contact_backup>
      <last_name>Concetta Chirico, PharmTechD</last_name>
      <phone>+34645494281</phone>
      <email>cchirico@trialance.com</email>
    </contact_backup>
    <investigator>
      <last_name>Jose Manuel Rubin Lopez, Cardiology</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Garcia Iglesias, Cardiology</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Diego Perez Diez, Cardiology</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Calvo Cuervo, Cardiology</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen del Puerto</name>
      <address>
        <city>Plasencia</city>
        <state>Madrid</state>
        <zip>28015</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marta Barbacid Hernández, PharmD, MSc</last_name>
      <phone>+34630767668</phone>
      <email>mbarbacid@trialance.com</email>
    </contact>
    <contact_backup>
      <last_name>Concetta Chirico, PharmTechD</last_name>
      <phone>+34645494281</phone>
      <email>cchirico@trialance.com</email>
    </contact_backup>
    <investigator>
      <last_name>David Rodriguez Palomo, Cardiology</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Puerto Real</name>
      <address>
        <city>Puerto Real</city>
        <state>Madrid</state>
        <zip>28015</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Barbacid Hernández, ParmD, MSc</last_name>
      <phone>+34630767668</phone>
      <email>mbarbacid@trialance.com</email>
    </contact>
    <contact_backup>
      <last_name>Concetta Chirico, PharmTechD</last_name>
      <phone>+34645494281</phone>
      <email>cchirico@trialance.com</email>
    </contact_backup>
    <investigator>
      <last_name>Francisco Javier Lozano Cid, Cardiology</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pablo Jose Gonzalez Perez, Cardiology</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Parc Taul'i</name>
      <address>
        <city>Sabadell</city>
        <state>Madrid</state>
        <zip>28015</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta B Barbacid Hernández, PharmD, MSc</last_name>
      <phone>+34630767668</phone>
      <email>mbarbacid@trialance.com</email>
    </contact>
    <contact_backup>
      <last_name>Concetta Chirico, PharmTechD</last_name>
      <phone>+34645494281</phone>
      <email>cchirico@trialance.com</email>
    </contact_backup>
    <investigator>
      <last_name>Gabriel Gusi Tragant, Cardiologist</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jordi Puntí Sala, Cardiologist</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antoni Martínez Rubio, Cardiologist</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jesus Ignaci Juménez Lopez, Cardiologist</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Marques de Valdecilla</name>
      <address>
        <city>Santander</city>
        <state>Madrid</state>
        <zip>28015</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Barbacid Hernández, PharmD, MSc</last_name>
      <phone>+34630767668</phone>
      <email>mbarbacid@trialance.com</email>
    </contact>
    <contact_backup>
      <last_name>Concetta Chirico, PharmTechD</last_name>
      <phone>+34645494981cchiric</phone>
      <email>cchirico@trialance.com</email>
    </contact_backup>
    <investigator>
      <last_name>Juan Jose Olalla, Cardiology</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Susana Gonzalez, Cardiology</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Rio Hortega</name>
      <address>
        <city>Valladolid</city>
        <state>Madrid</state>
        <zip>28015</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Barbacid Hernández, PharmD, MSc</last_name>
      <phone>+34630767668</phone>
      <email>mbarbacid@trialance.com</email>
    </contact>
    <contact_backup>
      <last_name>Concetta Chirico, PharmTechD</last_name>
      <phone>+34645494281</phone>
      <email>cchirico@trialance.com</email>
    </contact_backup>
    <investigator>
      <last_name>Benito Herreros, Cardiology</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sergio Madero, Cardiology</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitatis de Araba</name>
      <address>
        <city>Vitoria</city>
        <state>Madrid</state>
        <zip>28015</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Barbacid Hernández, PharmD, MSc</last_name>
      <phone>+34630767668</phone>
      <email>mbarbacid@trialance.com</email>
    </contact>
    <contact_backup>
      <last_name>Concetta Chirico, PharmTechD</last_name>
      <phone>+34645494281</phone>
      <email>cchirico@trialance.com</email>
    </contact_backup>
    <investigator>
      <last_name>Maria Robledo Iniarritu, Cardiology</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jon Orruño, Cardiology</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Santiago Garcia Mancebo, Cardiology</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General de Alicante</name>
      <address>
        <city>Alicante</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Concetta Chirico, PharmTechD</last_name>
      <phone>+34645494281</phone>
      <email>cchirico@trialance.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Barbacid Hernández, PhrmD, MSc</last_name>
      <phone>+34630767668</phone>
      <email>mbarbacid@trialance.com</email>
    </contact_backup>
    <investigator>
      <last_name>Juan Gabriel Martinez, Cardiology</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Raquel Ajo Ferrer, Cardiology</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital San Juan de Alicante</name>
      <address>
        <city>Alicante</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Concetta Chirico, PharmTechD</last_name>
      <phone>+34645494281</phone>
      <email>cchirico@trialance.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Barbacid Hernández, PharmD,MSc</last_name>
      <phone>+34630767668</phone>
      <email>mbarbacid@trialance.com</email>
    </contact_backup>
    <investigator>
      <last_name>Vicente Bartomeu Gonzalez, Cardiology</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Cruces</name>
      <address>
        <city>Barakaldo</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Barbacid Hernández, PharmD, MSc</last_name>
      <phone>+34630767668</phone>
      <email>mbarbacid@trialance.com</email>
    </contact>
    <contact_backup>
      <last_name>Concetta Chirico, PhamTechD</last_name>
      <phone>+34645494281</phone>
      <email>cchirico@trialance.com</email>
    </contact_backup>
    <investigator>
      <last_name>Ignacio Andres Bodegas Canas, Cardiology</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>I;into Sauna Godoy, MD,Cardiology</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Concetta Chirico, PharmTechD</last_name>
      <phone>+34645494281</phone>
      <email>cchirico@trialance.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Barbacid Hernández, PharmD, MSc</last_name>
      <phone>+34630767668</phone>
      <email>mbarbacid@trialance.com</email>
    </contact_backup>
    <investigator>
      <last_name>Jose Maria Tolosana, Cardiology</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rodolfo San Antonio, Cardiology</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Bellvitge</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Concetta Chirico, PharmTechD</last_name>
      <phone>+34645494281</phone>
      <email>cchirico@trialance.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Barbacid Hernández, PharmD, MSc</last_name>
      <phone>+34630767668</phone>
      <email>mbarbacid@trialance.com</email>
    </contact_backup>
    <investigator>
      <last_name>Ignasi Anguera Camós, Cardiology</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marcos Rodriguez, Cardiology</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Puerta de Hierro</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Barbacid Hernández, PharmD, MSc</last_name>
      <phone>+34630767668</phone>
      <email>mbarbacid@trialance.com</email>
    </contact>
    <contact_backup>
      <last_name>Concetta Chirirco, PharmTechD</last_name>
      <phone>+34645494281</phone>
      <email>cchirico@trialance.com</email>
    </contact_backup>
    <investigator>
      <last_name>Ignacio Fernández Lozano, Cardiologist</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Diego Jiménez Sánchez, Cardiologist</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Costa del Sol</name>
      <address>
        <city>Marbella</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Concetta Chirico, PharmTechD</last_name>
      <phone>+34645494281</phone>
      <email>cchirico@trialance.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Barbacid Hernández, PharmD, MSc</last_name>
      <phone>+34630767668</phone>
      <email>mbarbacid@trialance.com</email>
    </contact_backup>
    <investigator>
      <last_name>Francisco Ruiz Mateas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de la Victoria</name>
      <address>
        <city>Málaga</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Concetta Chirico, PharmTechD</last_name>
      <phone>+34 645494281</phone>
      <email>cchirico@trialance.com</email>
    </contact>
    <contact_backup>
      <last_name>Marta Barbacid, PharmD, MSc</last_name>
      <phone>+34 630767668</phone>
      <email>mbarbacid@trialance.com</email>
    </contact_backup>
    <investigator>
      <last_name>Javier Alzueta Rodríguez, Cardiologist</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thor Cruzado Maldonado, Cardiologist</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Marcu CB, Beek AM, van Rossum AC. Clinical applications of cardiovascular magnetic resonance imaging. CMAJ. 2006 Oct 10;175(8):911-7. Review.</citation>
    <PMID>17030942</PMID>
  </reference>
  <reference>
    <citation>Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994 Mar;96(3):200-9.</citation>
    <PMID>8154507</PMID>
  </reference>
  <reference>
    <citation>Kanal E, Borgstede JP, Barkovich AJ, Bell C, Bradley WG, Etheridge S, Felmlee JP, Froelich JW, Hayden J, Kaminski EM, Lester JW Jr, Scoumis EA, Zaremba LA, Zinninger MD; American College of Radiology. American College of Radiology White Paper on MR Safety: 2004 update and revisions. AJR Am J Roentgenol. 2004 May;182(5):1111-4.</citation>
    <PMID>15100103</PMID>
  </reference>
  <results_reference>
    <citation>Gold MR, Sommer T, Schwitter J, Al Fagih A, Albert T, Merkely B, Peterson M, Ciuffo A, Lee S, Landborg L, Cerkvenik J, Kanal E; Evera MRI Study Investigators. Full-Body MRI in Patients With an Implantable Cardioverter-Defibrillator: Primary Results of a Randomized Study. J Am Coll Cardiol. 2015 Jun 23;65(24):2581-2588. doi: 10.1016/j.jacc.2015.04.047. Epub 2015 May 14.</citation>
    <PMID>25982014</PMID>
  </results_reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>December 9, 2019</study_first_submitted>
  <study_first_submitted_qc>March 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2020</study_first_posted>
  <last_update_submitted>April 12, 2020</last_update_submitted>
  <last_update_submitted_qc>April 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Peacemaker</keyword>
  <keyword>implantable cardioverter-defibrillator</keyword>
  <keyword>Nuclear Magnetic Resonance</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

